.......becoming harder to justify use.............
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
Subscribe to:
Post Comments (Atom)
news stories and sundry information relevant to busy physicians and other health care providers interested in long term care.
No comments:
Post a Comment